| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/20/2006 | US20060161997 Methods for producing human antibodies in SCID mice |
| 07/20/2006 | US20060161996 Process for producing human-origin immunocompetent cell |
| 07/20/2006 | US20060161995 Chimeric mouse in which at least 85% of the human antibody-producing cells retain the human artificial chromosome Delta HAC or Delta Delta HAC. |
| 07/20/2006 | US20060160998 Methods for isolation and purification of fluorochrome-antibody conjugates |
| 07/20/2006 | US20060160997 Tumor-associated antigen specific immunoglobulin fusion for use in diagnosis, prevention and treatment of cell proliferative |
| 07/20/2006 | US20060160996 Optimized Fc variants and methods for their generation |
| 07/20/2006 | US20060160995 Thrombopoietin proteins with improved properties |
| 07/20/2006 | US20060160992 Method of identifying cells expressing a protein having pre-B cell growth-supporting ability |
| 07/20/2006 | US20060160991 Genes and polypeptides relating to prostate cancers |
| 07/20/2006 | US20060160731 Peptide nucleic acids |
| 07/20/2006 | US20060160723 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 07/20/2006 | US20060160246 Graphitic nanotubes in luminescence assays |
| 07/20/2006 | US20060160233 Ig heavy chain, ig kappa, ig lambda biopolymer markers predictive of alzheimers disease |
| 07/20/2006 | US20060160232 Complement c3 precursor biopolymer markers predictive of type ii diabetes |
| 07/20/2006 | US20060160184 Fab library for the preparation of anti VEGF and anti rabies virus fabs |
| 07/20/2006 | US20060160182 Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production |
| 07/20/2006 | US20060160178 Methods of generating antibody diversity in vitro |
| 07/20/2006 | US20060160174 Modified l49-sfv exhibiting increased stability and methods of use thereof |
| 07/20/2006 | US20060160163 Method of saying alastin digestion product and assay kit, method of detecting aortic dissection and detection kit |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060160157 Method, compositions and classification for tumor diagnostics and treatment |
| 07/20/2006 | US20060160154 Materials and methods for detection and treatment of breast cancer |
| 07/20/2006 | US20060160150 Solid phase synthesis; antibodies; kits |
| 07/20/2006 | US20060160149 G-coupled receptor showing selective affinity for ATP |
| 07/20/2006 | US20060160147 Recombinant cell line |
| 07/20/2006 | US20060160145 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs |
| 07/20/2006 | US20060160143 Mitogenic oxygenases |
| 07/20/2006 | US20060160139 Rhesus BCRP and antibodies thereto |
| 07/20/2006 | US20060160126 90 human secreted proteins |
| 07/20/2006 | US20060160091 Polynucleotides encoding a class II cytokine receptor |
| 07/20/2006 | US20060160090 Composition splice variants and methods relating to cancer specific genes and proteins |
| 07/20/2006 | US20060160082 Novel genes and proteins encoded thereby |
| 07/20/2006 | US20060160068 Fluorescent phosphophenol ligand analog of a reporter moleculeof a borapolyazaindacene, a coumarin, a xanthene, a cyanine, a fluorescent protein, or a phosphorescent dye covalently bonded through a linker |
| 07/20/2006 | US20060159718 Method for the production of porous carbon-based molded bodies, and use thereof as cell culture carrier systems and culture systems |
| 07/20/2006 | US20060159693 Idiotypic vaccine |
| 07/20/2006 | US20060159691 Ptprk immunogenic peptide |
| 07/20/2006 | US20060159690 H-Y antigen |
| 07/20/2006 | US20060159687 Modified aerolysin and methods of use for treating lung cancer |
| 07/20/2006 | US20060159686 Natural killer cell activating factor II |
| 07/20/2006 | US20060159685 Of given sequence; immunomodulators; prophylaxis or treatments for cancers |
| 07/20/2006 | US20060159684 Compositions and methods for the threatment of sepsis |
| 07/20/2006 | US20060159683 Stabilization of chimeric immunoglobulin; obtain immunoglobulin, monitor structure, determine sequence, adjust amino acid sequences for greater stability |
| 07/20/2006 | US20060159682 Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof |
| 07/20/2006 | US20060159677 Tumour necrosis factor peptide binding antibodies |
| 07/20/2006 | US20060159675 Compositions and methods for treating coagulation related disorders |
| 07/20/2006 | US20060159673 Methods of screening light chain of antibody |
| 07/20/2006 | US20060159672 Identification of self and non-self antigens implicated in autoimmune diseases |
| 07/20/2006 | US20060159662 Therapeutic anti-melanoma compounds |
| 07/20/2006 | US20060159654 Interacting the immature dendritic cells with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE; an increased viability relative to a control dendritic cell not contacted with TRANCE |
| 07/20/2006 | DE102005001191A1 Vorrichtung und Verfahren zur Fraktionierung von Mono- und/oder Oligosaccharid-Strukturen Device and method for the fractionation of the mono- and / or oligosaccharide structures |
| 07/20/2006 | CA2609109A1 Forms of factor xiia |
| 07/20/2006 | CA2595169A1 Antibodies and fc fusion proteins with altered immunogenicity |
| 07/20/2006 | CA2594922A1 Monoclonal antibodies that bind or neutralize hepatitis b virus |
| 07/20/2006 | CA2594572A1 Nitrogen-regulated sugar sensing gene and protein and modulation thereof |
| 07/20/2006 | CA2594318A1 Irta-2 antibodies and their uses |
| 07/20/2006 | CA2593786A1 Kid31 and antibodies that bind thereto |
| 07/20/2006 | CA2593777A1 Anti-.alpha.9 integrin antibody and the use thereof |
| 07/19/2006 | EP1681351A1 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides Spp. |
| 07/19/2006 | EP1681350A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 07/19/2006 | EP1681348A1 MU-1 member of the cytokine receptor family |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 07/19/2006 | EP1680500A2 High temperature and alkaline stable catalase |
| 07/19/2006 | EP1680449A1 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications therof |
| 07/19/2006 | EP1680448A2 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene |
| 07/19/2006 | EP1680141A2 Methods of therapy for solid tumors expressing the cd40 cell-surface antigen |
| 07/19/2006 | EP1680140A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 07/19/2006 | EP1497646A4 Peptide biomarker and method of identification |
| 07/19/2006 | EP1404428B1 Methods for purifying highly anionic proteins |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1131421B1 Methods for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof |
| 07/19/2006 | EP1082967B1 Prevention and treatment of autoimmune demyelinating diseases by Fas-antagonists |
| 07/19/2006 | EP0835447B1 Novel peptides and compositions which modulate apoptosis |
| 07/19/2006 | EP0690724B1 Chlamydia vaccine comrising anti-idiotypic antibodies |
| 07/19/2006 | CN1806175A Method of diagnosing SARS corona virus infection |
| 07/19/2006 | CN1806172A Method for selecting and producing vaccine components and vaccines based thereon |
| 07/19/2006 | CN1805757A Recombinant antibodies, and compositions and methods for making and using the same |
| 07/19/2006 | CN1805755A Therapeutic use of anti- CS1 antibodies |
| 07/19/2006 | CN1805754A Functionally reconstituted viral membranes containing adjuvant |
| 07/19/2006 | CN1804039A Virulence genes, proteins, and their use |
| 07/19/2006 | CN1803844A Monoclonal antibody ZUB1 of human bone marrow mesenchymal stem cells and application thereof |
| 07/19/2006 | CN1803843A Monoclonal antibody ZUF10 of human bone marrow mesenchymal stem cells and application |
| 07/19/2006 | CN1803842A Antibody for treating or preventing senile dementia, its expression vector and application in drug preparation |
| 07/19/2006 | CN1803841A Single chain antibody of HIV1//2 antigen and quick detection reagent thereof |
| 07/19/2006 | CN1803837A Neurotrophic growth factor |
| 07/19/2006 | CN1803833A Gene for inhibiting human transcription factor AP-1, its encoding polypeptide and uses |
| 07/19/2006 | CN1264980C Novel tumor antigen protein SART-3 and tumor antigen peptide thereof |
| 07/19/2006 | CN1264859C Monoclonal antibody of anti human P-selectin lectin-EGF domain and preparation method and application thereof |
| 07/19/2006 | CN1264857C Recombinant fusion protein (vaccine), composition containing the same and method for prodution thereof |
| 07/19/2006 | CN1264833C Nonviscous protein type synthetic compound or its carrier combined compound |
| 07/18/2006 | US7078516 Nucleotide sequences derived from the genome of retroviruses of the hiv-1, hiv-2 and siv type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078513 plasmid is a viral or bacterial expression vector and is expressed in a prokaryotic or eukaryotic cell; gene therapy and immunotherapy; prenatal screening and diagnosis |
| 07/18/2006 | US7078506 Canineil-4nucleic acid molecules and uses thereof |
| 07/18/2006 | US7078504 Enzymes having dehalogenase activity and methods of use thereof |
| 07/18/2006 | US7078495 minimal cross reactivity with tacolimus metaolites; antibody is conjugated with a detectable label; sample reacted with an enzyme labelled tacrolimus analogue, total signal present is measured; test kits |
| 07/18/2006 | US7078494 Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding |
| 07/18/2006 | US7078493 Antibodies to human tumor necrosis factor receptor-like genes |
| 07/18/2006 | US7078492 Human antipneumococcal antibodies from non-human animals |
| 07/18/2006 | US7078491 Selective binding agents of telomerase |
| 07/18/2006 | US7078490 Artificial antibody polypeptides |